Adverum Biotechnologies
$4.36
45
+$0.1+2.35% Monday 21:00
Statistics
Day High
4.38
Day Low
4.23
52W High
5.75
52W Low
1.78
Volume
675,984
Avg. Volume
745,513
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
1AprExpected
Expected EPS
-1.63
Actual EPS
N/A
Financials
-13,092.7%Profit Margin
Unprofitable1MRevenue
-130.93MNet Income
Analyst Ratings
$4.50Average Price Target
The highest estimate is 5.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ADVM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regenxbio
RGNX
Mkt Cap645.07M
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Novartis
NVS
Mkt Cap237.61B
Biogen
BIIB
Mkt Cap22.63B
Abeona Therapeutics
ABEO
Mkt Cap246.65M
Pfizer
PFE
Mkt Cap140.15B
GSK
GSK
Mkt Cap94.51B
About
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Show more...
CEO
Dr. Laurent Fischer M.D.
Employees
155
Country
US
ISIN
US00773U2078
Listings
0 Comments
Share your thoughts
FAQ
What is Adverum Biotechnologies stock price today?▼
The current price of ADVM is $4.36 USD — it has increased by +2.35% in the past 24 hours. Watch Adverum Biotechnologies stock price performance more closely on the chart.
What is Adverum Biotechnologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adverum Biotechnologies stocks are traded under the ticker ADVM.
Is Adverum Biotechnologies stock price growing?▼
ADVM stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Adverum Biotechnologies has showed a +13.84% increase.
What is Adverum Biotechnologies revenue for the last year?▼
Adverum Biotechnologies revenue for the last year amounts to 1M USD.
What is Adverum Biotechnologies net income for the last year?▼
ADVM net income for the last year is -130.93M USD.
How many employees does Adverum Biotechnologies have?▼
As of April 01, 2026, the company has 155 employees.
In which sector is Adverum Biotechnologies located?▼
Adverum Biotechnologies operates in the Health Care sector.
When did Adverum Biotechnologies complete a stock split?▼
The last stock split for Adverum Biotechnologies was on March 21, 2024 with a ratio of 1:10.
Where is Adverum Biotechnologies headquartered?▼
Adverum Biotechnologies is headquartered in Redwood City, US.